Xchanging Solutions Limited (NSE:XCHANGING)

Verve Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	2,999	3,077	5,149	4,398	3,911
Short-Term Investments	-	-	-	1	-
Cash & Short-Term Investments	2,999	3,077	5,149	4,399	3,911
Cash Growth	-2.52%	-40.24%	17.05%	12.45%	20.03%
Accounts Receivable	262.4	254.6	261.4	313.3	272
Other Receivables	7.6	1.1	7.1	1.5	1.6
Receivables	270.3	257	270.1	406.4	274.6
Prepaid Expenses	8.4	8.4	6.6	7.2	9.4
Other Current Assets	9.6	28.2	3.4	12.3	14.1
Total Current Assets	3,288	3,371	5,429	4,824	4,210
Property, Plant & Equipment	0.4	10.6	15.4	21.3	17.4
Goodwill	1,584	1,584	1,584	1,584	1,584
Other Intangible Assets	-	-	0.1	0.2	0.3
Long-Term Accounts Receivable	-	-	-	-	10.1
Long-Term Deferred Tax Assets	-	-	-	18.7	43.8
Other Long-Term Assets	170.2	265.4	241.5	242.7	222.5
Total Assets	5,042	5,231	7,432	6,763	6,250
Accounts Payable	175.5	162.1	136.2	144.8	205.1
Accrued Expenses	25.4	38.4	34.1	33.5	40.2
Current Portion of Long-Term Debt	213.7	-	-	-	-
Current Portion of Leases	-	3.7	4	3.8	8.5
Current Income Taxes Payable	265.3	326.8	359.3	367.1	353.7
Current Unearned Revenue	13.5	6.6	5.3	12	8.1
Other Current Liabilities	26.1	16.1	7.2	13.8	20.1
Total Current Liabilities	719.5	553.7	546.1	575	635.7
Long-Term Debt	641	1,043	-	-	-
Long-Term Leases	-	6.3	9.4	13.4	18
Long-Term Deferred Tax Liabilities	83.9	74.3	71.7	-	-
Other Long-Term Liabilities	11.3	11.1	11.3	11.1	11.8
Total Liabilities	1,456	1,691	669.4	628.7	692.6
Common Stock	1,114	1,114	1,114	1,114	1,114
Additional Paid-In Capital	841.7	841.7	841.7	841.7	841.7
Retained Earnings	1,303	1,249	4,452	4,005	3,481
Comprehensive Income & Other	328.1	335	354.9	174.2	120.3
Shareholders' Equity	3,587	3,539	6,762	6,135	5,557
Total Liabilities & Equity	5,042	5,231	7,432	6,763	6,250
Total Debt	854.7	1,053	13.4	17.2	26.5
Net Cash (Debt)	2,145	2,024	5,135	4,381	3,885
Net Cash Growth	5.95%	-60.58%	17.21%	12.78%	20.06%
Net Cash Per Share	19.25	18.17	46.10	39.33	34.87
Filing Date Shares Outstanding	111.4	111.4	111.4	111.4	111.4
Total Common Shares Outstanding	111.4	111.4	111.4	111.4	111.4
Working Capital	2,568	2,817	4,883	4,249	3,574
Book Value Per Share	32.20	31.77	60.70	55.07	49.88
Tangible Book Value	2,003	1,955	5,178	4,550	3,973
Tangible Book Value Per Share	17.98	17.55	46.48	40.84	35.66
Machinery	16.5	43.7	82.5	99.9	107.2
Leasehold Improvements	0.6	0.6	2.1	2.1	1.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.